Elaine Morgan, MD

Biography

Attending Physician, Hematology, Oncology, Neuro-Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago
The Bridges Program—Pediatric Palliative and End-of-Life Care, Ann & Robert H. Lurie Children’s Hospital of Chicago
Professor of Pediatrics, Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

Fellowship in Hematology/Oncology, Children's Hospital Boston 1974-1975
Residency in Pediatrics, Children's Hospital Los Angeles 1972-1974
MD, University of Pennsylvania School of Medicine 1971

Clinical Studies

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Recruiting

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Recruiting

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

Publications

May. 23, 2023

Bridge or Destination: Ethical Complexity, Emotional Unrest.

May. 02, 2023

Integrating the patients' voice in designing and delivering a research study: The Yorkshire Cancer Research funded PREHABS study's experience.

Apr. 25, 2022

Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.

See all publications

Similar Researchers

Kevin McNerney, MD

Research Interests

CAR T-cell Therapy, CAR T-cell Toxicities, Immunotherapy, Hematopoietic Stem Cell Transplant, Leukemia

Recent Publication

Mediport use as an acceptable standard for CAR T cell infusion.

Oct. 27, 2023

Medicolegal Challenges to Death by Neurologic Criteria in the United Kingdom and the United States: Lessons Learned from the Case of Archie Battersbee and a Suggestion for Mid-Level Principles to Enhance an Ongoing Dialogue.

Jan. 18, 2024

Ashley S. Plant-Fox, MD

Research Interests

Pediatric Neuro-Oncology, Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma, High Grade Glioma, Immunotherapy, Targeted Therapies, Health Disparities

Recent Publication

An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.

Sep. 01, 2022

Jennifer Hoffmann, MD

Research Interests

Pediatric Mental Health Emergencies, Pediatric Firearm Injury Prevention, Access to Healthcare, Social Determinants of Health, Child Health Advocacy

Recent Publication

A Holistic Approach to Childhood Firearm Injuries.

Dec. 13, 2023

Todd Florin, MD, MSCE

Research Interests

Pediatric Respiratory Infections, Pediatric Emergency Medicine, Clinical and Molecular Epidemiology, Antimicrobial Stewardship, Predictive Analytics

Recent Publication

Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.

Mar. 26, 2024

Kendra M. Ward, MD, MSCI

Recent Publication

The Child Opportunity Index 2.0 and Disparities in Pediatric Cardiorespiratory Fitness.

Feb. 17, 2024